Hikma, Glenmark Specialty launch RyaltrisRyaltris is used for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. Endo files for Chapter 11 bankruptcyEndo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in New York. Upsher-Smith, Emphascience ink deal for specialty branded generic product Emphascience will develop the product exclusively for Upsher-Smith, which will manufacture, market and distribute it under its own label in the United States. Israel Makov to retire as chairman of Sun Pharma After having led for 10 years, Makov is retiring as Sun Pharma's chairman and member of the board. Amber Specialty Pharmacy to dispense Pfizer's oncology portfolio Amber Specialty Pharmacy will begin dispensing 13 Pfizer oncology products. Marinus launches Ztalmy Ztalmy is the only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients 2 years of age and older. Surescripts Specialty Medications Solutions to transform process for prescriptions, savings In May 2022, prescribers used Real-Time Prescription Benefit to save patients an average of $534.74 per specialty prescription. Sun Pharma, Cassiopea expand license, supply agreement for Winlevi Sun Pharma and Cassiopea will bring Winlevi to patients in Japan, Australia, New Zealand, Brazil, Mexico and Russia. Nobelpharma America debuts Hyftor Hyftor is used to treat facial angiofibroma associated with tuberous sclerosis complex for patients 6 years and older. Amber Specialty Pharmacy expands Evusheld services The Hy-Vee subsidiary will offer Evusheld at its 19 locations throughout the U.S. First Previous 6 7 8 9 10 Next Last